530219 Stock Overview
Engages in the research and development of isolating plants protein in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Nutricircle Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹225.15 |
| 52 Week High | ₹280.00 |
| 52 Week Low | ₹195.10 |
| Beta | 1 |
| 11 Month Change | -9.94% |
| 3 Month Change | -17.62% |
| 1 Year Change | 15.14% |
| 33 Year Change | 200.80% |
| 5 Year Change | 380.06% |
| Change since IPO | 650.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| 530219 | IN Personal Products | IN Market | |
|---|---|---|---|
| 7D | -5.0% | -1.8% | 0.3% |
| 1Y | 15.1% | 0.9% | 27.3% |
Return vs Industry: 530219 exceeded the Indian Personal Products industry which returned 1.3% over the past year.
Return vs Market: 530219 underperformed the Indian Market which returned 27.2% over the past year.
Price Volatility
| 530219 volatility | |
|---|---|
| 530219 Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 530219's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine 530219's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 3 | Mohan Patel | nutricircle.in |
Nutricircle Limited engages in the research and development of isolating plants protein in India. It offers bajra, jowar, kangni, quinoa, rajgiri, mung beans, rajma, masoor dal, and kala chana. The company also provides My 45 Nutrients, an immunity supplement; GoSlender, a weight loss tablets; and Fly High, a supplement capsules.
Nutricircle Limited Fundamentals Summary
| 530219 fundamental statistics | |
|---|---|
| Market cap | ₹61.19m |
| Earnings (TTM) | -₹13.55m |
| Revenue (TTM) | ₹21.06m |
2.9x
P/S Ratio-4.5x
P/E RatioIs 530219 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 530219 income statement (TTM) | |
|---|---|
| Revenue | ₹21.06m |
| Cost of Revenue | ₹21.20m |
| Gross Profit | -₹143.00k |
| Other Expenses | ₹13.40m |
| Earnings | -₹13.55m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -49.84 |
| Gross Margin | -0.68% |
| Net Profit Margin | -64.33% |
| Debt/Equity Ratio | -123.8% |
How did 530219 perform over the long term?
See historical performance and comparison